Your browser doesn't support javascript.
loading
Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.
Alladina, Jehan; Levy, Sean D; Cho, Josalyn L; Brait, Kelsey L; Rao, Sowmya R; Camacho, Alexander; Hibbert, Kathryn A; Harris, R Scott; Medoff, Benjamin D; Januzzi, James L; Thompson, B Taylor; Bajwa, Ednan K.
Afiliação
  • Alladina J; Division of Pulmonary and Critical Care Medicine and.
  • Levy SD; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Cho JL; Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
  • Brait KL; Division of Pulmonary and Critical Care Medicine and.
  • Rao SR; Boston University School of Public Health, Boston, Massachusetts; and.
  • Camacho A; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
  • Hibbert KA; Division of Pulmonary and Critical Care Medicine and.
  • Harris RS; Division of Pulmonary and Critical Care Medicine and.
  • Medoff BD; Vertex Pharmaceuticals, Boston, Massachusetts.
  • Januzzi JL; Division of Pulmonary and Critical Care Medicine and.
  • Thompson BT; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
  • Bajwa EK; Division of Pulmonary and Critical Care Medicine and.
Am J Respir Crit Care Med ; 203(10): 1257-1265, 2021 05 15.
Article em En | MEDLINE | ID: mdl-33400890
Rationale: Standard physiologic assessments of extubation readiness in patients with acute hypoxemic respiratory failure (AHRF) may not reflect lung injury resolution and could adversely affect clinical decision-making and patient outcomes. Objectives: We hypothesized that elevations in inflammatory plasma biomarkers sST2 (soluble suppression of tumorigenicity-2) and IL-6 indicate ongoing lung injury in AHRF and better inform patient outcomes compared with standard clinical assessments. Methods: We measured daily plasma biomarkers and physiologic variables in 200 patients with AHRF for up to 9 days after intubation. We tested the associations of baseline values with the primary outcome of unassisted breathing at Day 29. We analyzed the ability of serial biomarker measurements to inform successful ventilator liberation. Measurements and Main Results: Baseline sST2 concentrations were higher in patients dead or mechanically ventilated versus breathing unassisted at Day 29 (491.7 ng/ml [interquartile range (IQR), 294.5-670.1 ng/ml] vs. 314.4 ng/ml [IQR, 127.5-550.1 ng/ml]; P = 0.0003). Higher sST2 concentrations over time were associated with a decreased probability of ventilator liberation (hazard ratio, 0.80 per log-unit increase; 95% confidence interval [CI], 0.75-0.83; P = 0.03). Patients with higher sST2 concentrations on the day of liberation were more likely to fail liberation compared with patients who remained successfully liberated (320.9 ng/ml [IQR, 181.1- 495.6 ng/ml] vs. 161.6 ng/ml [IQR, 95.8-292.5 ng/ml]; P = 0.002). Elevated sST2 concentrations on the day of liberation decreased the odds of successful liberation when adjusted for standard physiologic parameters (odds ratio, 0.325; 95% CI, 0.119-0.885; P = 0.03). IL-6 concentrations did not associate with outcomes. Conclusions: Using sST2 concentrations to guide ventilator management may more accurately reflect underlying lung injury and outperform traditional measures of readiness for ventilator liberation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Desmame do Respirador / Proteína 1 Semelhante a Receptor de Interleucina-1 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Desmame do Respirador / Proteína 1 Semelhante a Receptor de Interleucina-1 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2021 Tipo de documento: Article